WSTWEST PHARMACEUTICAL SERVICE...

NYSE westpharma.com


$ 293.49 $ -3.29 (-1.11 %)    

Tuesday, 17-Sep-2024 14:14:55 EDT
QQQ $ 473.06 $ -2.91 (-0.61 %)
DIA $ 417.40 $ -0.58 (-0.14 %)
SPY $ 562.82 $ -2.31 (-0.41 %)
TLT $ 100.91 $ -0.48 (-0.47 %)
GLD $ 237.56 $ -0.42 (-0.18 %)
$ 296.78
$ 297.66
$ 293.41 x 100
-- x --
$ 293.11 - $ 298.83
$ 264.82 - $ 413.20
425,356
na
21.53B
$ 0.90
$ 41.02
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-25-2024 06-30-2024 10-Q
2 04-25-2024 03-31-2024 10-Q
3 02-20-2024 12-31-2023 10-K
4 10-26-2023 09-30-2023 10-Q
5 07-27-2023 06-30-2023 10-Q
6 04-27-2023 03-31-2023 10-Q
7 02-21-2023 12-31-2022 10-K
8 10-27-2022 09-30-2022 10-Q
9 07-28-2022 06-30-2022 10-Q
10 04-28-2022 03-31-2022 10-Q
11 02-22-2022 12-31-2021 10-K
12 10-28-2021 09-30-2021 10-Q
13 07-30-2021 06-30-2021 10-Q
14 04-30-2021 03-31-2021 10-Q
15 02-23-2021 12-31-2020 10-K
16 10-23-2020 09-30-2020 10-Q
17 07-24-2020 06-30-2020 10-Q
18 04-24-2020 03-31-2020 10-Q
19 02-24-2020 12-31-2019 10-K
20 10-29-2019 09-30-2019 10-Q
21 07-29-2019 06-30-2019 10-Q
22 05-08-2019 03-31-2019 10-Q
23 02-28-2019 12-31-2018 10-K
24 10-30-2018 09-30-2018 10-Q
25 07-31-2018 06-30-2018 10-Q
26 05-08-2018 03-31-2018 10-Q
27 02-26-2018 12-31-2017 10-K
28 10-31-2017 09-30-2017 10-Q
29 08-01-2017 06-30-2017 10-Q
30 05-05-2017 03-31-2017 10-Q
31 02-28-2017 12-31-2016 10-K
32 10-31-2016 09-30-2016 10-Q
33 08-01-2016 06-30-2016 10-Q
34 05-06-2016 03-31-2016 10-Q
35 02-26-2016 12-31-2015 10-K
36 11-02-2015 09-30-2015 10-Q
37 08-03-2015 06-30-2015 10-Q
38 05-06-2015 03-31-2015 10-Q
39 02-25-2015 12-31-2014 10-K
40 11-03-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 sp-500-nasdaq-100-mark-seventh-straight-positive-session-strongest-week-since-october-2023-fridays-top-movers

S&P 500 and Nasdaq 100 indices gain for seventh straight day, marking best weekly performance since October 2023 on positiv...

 ford-stellantis-and-dell-are-among-top-12-large-cap-losers-last-week-july-21-july-27-are-the-others-in-your-portfolio

Top 10 worst performers last week: EW (-28.05%), F (-19.12%), STM (-17.60%), TER (-16.25%), MBLY (-14.61%), STLA (-13.07%), VRT...

 west-pharmaceutical-services-updates-full-year-2024-net-sales-guidance-to-287b-29b-versus-prior-guidance-of-3b-3025b-and-consensus-of-3012b

The Company is updating full-year 2024 net sales guidance to a range of $2.870 billion to $2.900 billion, compared to a prior...

 west-pharmaceutical-servs-q1-2024-adj-eps-156-beats-126-estimate-sales-695400m-beat-670303m-estimate

West Pharmaceutical Servs (NYSE:WST) reported quarterly earnings of $1.56 per share which beat the analyst consensus estimate o...

 sp-reclaims-5000-as-disappointing-retail-sales-put-fed-cuts-back-on-track-small-caps-shine-whats-driving-markets-thursday

US stocks surge on strong earnings and speculation of Fed rate cuts. S&P 500 rebounds past 5000, Nasdaq 100 pauses. Small c...

 why-herbalife-shares-are-trading-lower-by-around-36-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Herbalife Ltd. (NYSE: HLF) fell sharply in today’s session following weak quarterly earnings.

 west-pharmaceuticals-2024-outlook-cautious-analysts-remain-optimistic

West Pharmaceutical Services reports Q4 2023 adjusted EPS at $1.83, surpassing consensus. Quarterly sales hit $732 million miss...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION